AKT1 and prostate cancer: A major finding from the current study is that the lack of Akt1 in HLECs promotes prostate cancer cell transendothelial migration in vitro and metastasis to the mouse lungs in vivo involving increased nuclear localisation of β-catenin and suppression of endothelial tight-junction proteins.